Quadrature Capital’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-44,274
Closed -$628K 1317
2025
Q4
$628K Buy
+44,274
New +$838K 0.01% 636
2025
Q3
Sell
-51,863
Closed -$1.18M 1000
2025
Q2
$1.18M Buy
+51,863
New +$1.23M 0.02% 385
2020
Q4
Sell
-13,190
Closed -$389K 801
2020
Q3
$389K Buy
+13,190
New +$383K 0.02% 528
2019
Q1
Sell
-22,582
Closed -$581K 520
2018
Q4
$581K Buy
+22,582
New +$782K 0.11% 229
2018
Q2
Sell
-5,192
Closed -$203K 491
2018
Q1
$203K Sell
5,192
-38,568
-88% -$1.41M 0.02% 550
2017
Q4
$1.43M Buy
+43,760
New +$1.52M 0.13% 176
2017
Q1
Sell
-12,267
Closed -$406K 626
2016
Q4
$406K Buy
+12,267
New +$476K 0.03% 471
2015
Q4
Sell
-13,608
Closed -$902K 425
2015
Q3
$902K Buy
+13,608
New +$1.05M 0.3% 106

Other funds holding ACHC

Quadrature Capital's ACHC Position: Q1 2026 in Review

Quadrature Capital sold out of Acadia Healthcare (ACHC) in Q1 2026, closing a stake of 44,274 shares — an estimated $628K sold.

Quadrature Capital first reported a position in ACHC in Q3 2015 and held it in 8 quarters. The position peaked at $1.43M in Q4 2017. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Quadrature Capital reported no remaining Acadia Healthcare position as of Q1 2026 after selling out during the quarter.
  • Quadrature Capital sold 44,274 Acadia Healthcare shares in Q1 2026, an estimated $628K.
  • Quadrature Capital first reported a position in Acadia Healthcare in Q3 2015 and held it in 8 quarters.
  • Quadrature Capital's Acadia Healthcare position peaked at $1.43M in Q4 2017.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.